• Online Features  This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (5)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Viral Infections  • Dermatology  • Dermatologic Disorders  • Public Health  • Immunization  • Dermatologic Disorders, Other  • Drug Therapy  • Adverse Effects  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Thomas M. Beachkofsky, MD; Scott C. Carrizales, MD; Jeffrey J. Bidinger, MD; David E. Hrncir, MD, MPH; Darren E. Whittemore, DO; Chad M. Hivnor, MD, FAAD

Arch Dermatol. 2010;146(6):656-661.

Background  Generalized vaccinia and benign exanthems are 2 adverse events that have been associated with the smallpox vaccination. Accurate incidence and prevalence rates of each are not readily available, but these events are thought to be uncommon. To our knowledge, this is the first case series to provide clinical as well as pathologic descriptions of multiple papulovesicular eruptions occurring after receiving the second-generation smallpox vaccine, ACAM2000 (Acambis, Canton, Massachusetts), among a vaccinia-naïve military population. In addition, we report the first confirmed case, to our knowledge, of generalized vaccinia following administration of the ACAM2000 vaccine.

Observations  All patients received primary smallpox immunization as well as 1 to 3 concurrent or near-concurrent (within the preceding 21 days) immunizations for typhoid, anthrax, hepatitis B, and/or seasonal influenza. One patient presented with a flulike prodrome and diffuse vesiclopustules covering the face, neck, chest, back, and upper and lower extremities. Vaccinia polymerase chain reaction confirmed generalized vaccinia. The remaining 7 patients presented with unusual, painful, and pruritic papulovesicular eruptions occurring on the extensor surfaces of their upper and lower extremities without systemic symptoms. Histologic findings revealed 2 general patterns, including a dermal hypersensitivity reaction with lymphocytic vasculitis and a vesicular spongiotic dermatitis with eosinophils.

Conclusions  We present the first confirmed case of generalized vaccinia following immunization with the second-generation smallpox vaccine ACAM2000. In addition, we describe 7 cases of benign, acral, papulovesicular eruptions thought to be associated with ACAM2000 administration. Further research is needed to discern the pathogenesis of these benign eruptions as well as their incidence and prevalence and that of generalized vaccinia with ACAM2000.

Author Affiliations: Wilford Hall Medical Center (Dr Beachkofsky), Departments of Dermatology (Drs Carrizales, Bidinger, and Hivnor) and Pathology (Dr Whittemore), and Vaccine Healthcare Center (Dr Hrncir), Lackland Air Force Base, Texas.

CiteULike    Connotea    Delicious    Digg    Facebook    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Eczema Vaccinatum
Reed et al.
Clinical Infectious Diseases 2012;0:cir952v1-cir952.
ABSTRACT | FULL TEXT  

'ASIA': a new systemic autoimmune syndrome?
Cervera
Lupus 2011;20:665-666.
FULL TEXT  

Smallpox Vaccine Safety Is Dependent on T Cells and Not B Cells
Gordon et al.
The Journal of Infectious Disease 2011;203:1043-1053.
ABSTRACT | FULL TEXT